Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma

BACKGROUND: Osteosarcoma (OS) is a malignant bone tumor that often develops during the period of rapid growth associated with adolescence. Despite successful primary tumor control accompanied by adjuvant chemotherapy, death from pulmonary metastases occurs in approximately 30% of patients within 5 y...

詳細記述

保存先:
書誌詳細
出版年:Cancer Metab
主要な著者: Ren, L., Ruiz-Rodado, V., Dowdy, T., Huang, S., Issaq, S. H., Beck, J., Wang, H., Tran Hoang, C., Lita, A., Larion, M., LeBlanc, A. K.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057558/
https://ncbi.nlm.nih.gov/pubmed/32158544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40170-020-0209-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料